The AACR remains fully committed to supporting publishing operations throughout this challenging time, while still remaining flexible and supportive of the author, reviewer, and editor communities that we serve. If you have any questions or concerns, please reach out to a member of the AACR publishing staff.
Follow us on Twitter @CD_AACR
News from Cancer Discovery
- Concurrent Mutations in Oncogenes Functionally Relevant
Aberrations affecting the same gene appear common in cancer. - Gilead Buys into Tizona's Anti–HLA-G Strategy
Deal covers potential first-in-class checkpoint inhibitor in early-stage clinical testing. - Proteogenomics Clarifies Picture of Lung Cancer
Trio of studies identifies molecular differences in patients from East Asia, pinpoints new treatment targets. - Anti-BCMA Therapy Endorsed, despite Eye Toxicity
Possible benefits of belantamab mafodotin found to outweigh risks for some patients with multiple myeloma.
Advertisement
